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Abstract 
In this work, we demonstrate a promising polysilicon nanowire (poly-Si NW) biosensor platform.  Several 
biomarkers, such as N-terminal prohormone brain natriuretic peptide (NT-proBNP), Low-density lipoprotein (LDL), 
Hemoglobin (Hb), and Hemoglobin A1C (HbA1c), for heart disease and diabetes are experimentally examined by 
the developed platform.  Based on experimental results, the sensor responses of each biomarker is suitable for 
clinical diagnoses.  Compared with conventional examination methods, using polysilicon nanowire biosensor not 
only reduce the inspection time but also economize the cost of diagnoses. Moreover, these implemented biosensor 
platform are made by a standard complementary metal-oxide-semiconductor (CMOS) process.  Based on this
technology, the developed devices can be easily integrated with different functional modules, such wireless and 
microfluidic systems.  Therefore, this work demonstrates a good potential of CMOS based biosensor platform to 
accomplish the need of early diagnosis and point-of-care testing (POCT) system. 
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continuously applied on poly-Si NW to form the function group for 1 hour. Last, antibodies were immobilized. 
Before measurement, BSA was applied to block the unbinding site of antibodies. 
The measurement setup is shown in Fig. 1 (b). The measurement procedure can be briefly described as follows: 
(a) Inject phosphate buffered saline (PBS) buffer solution for 5 minutes to obtain a reference base line; (b) Inject and 
incubate a specific concentration of testing target biomarker for 8 minutes; (c) remove unbinding biomarkers by 
PBS buffer; (d) measure the output voltage with PBS buffer. 
3. Measurement results 
NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure. In addition, 
higher levels of LDL particles are associated with health problems, including cardiovascular disease. Furthermore, 
the ratio of HbA1c to Hb is an index of diabetes diagnosis. The higher ratio of HbA1c to Hb indicates the higher 
risks of developing complications related to diabetes. The normal range of Hb is 13.5 to 17.5 g/dl (135 to 175 mg/ml) 
for men, 12.0 to 15.5 g/dl (125 to 155 mg/ml) for women. And the normal range of HbA1c in plasma is about 4% to 
5.6% of Hb concentration. In this work, the detection range of all biomarkers was designed for clinical diagnoses. 
The responses of different biomarkers can be shown in Fig. 2. As the figure shown, with different biomarkers, the 
output responses increased with higher biomarker concentration. The demarcation in clinical diagnoses of NT-
proBNP and LDL are 463 pM and 700 µg/ml. On other hand, on Hb and HbA1c detection, the samples need to be 
diluted 10,000 times in order to avoid signal saturation. The clinical diagnoses level after 10,000 times diluted of Hb 
and HbA1c are 10 µg/ml and 71 nM.  
                                                                           
Fig. 2.  The experimental results response of (a) NT-proBNP (b) LDL (c) Hb (d) HbA1C detection . 
Detail experiment parameters are also shown in Table 1. The different outcomes between different proteins are 
caused by the different target concentrations, binding efficiency and isoelectric point value issue [12, 13].  Because 
the isoelectric point values of Hb and HbA1C are close to PBS pH value, we regulated the pH value of the PBS to 
pH 8 in order to enhance the signal responses. Based on this work, it is promising to employ the developed CMOS 
based poly-Si NW biosensor platform for POCT system. 
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Table 1 Detail experiment parameters of four biological indicators, NT-proBNP, LDL, Hb and HbA1c, in this research. The detection range of all 
biomarkers was designed for clinical diagnoses. 
Biological 
Markers 
Detection Range 
Isoelectric  
Point Value 
Measurement  
Buffer pH Value 
Clinical  
Diagnoses level 
NT-proBNP 32 pM ~ 32 nM 9.9 7.4 463 pM 
LDL 1 µg/ml ~ 1 mg/ml 5.4 7.4 700 ƶg/ml 
Hb 100 ng/ml ~ 100 ƶg/ml 6.852 8.0 10 ƶg/ml 
HbA1c 4 nM ~400 nM 6.75 8.0 71 nM 
4. Conclusion  
In this paper, a poly-Si NW biosensor is successfully realized in a 0.35 ȝm 2P4M commercially-available CMOS   
process. The experimental results show that the biosensor chip can successfully detect the concentration difference 
in clinical diagnoses level. Consequently, with the advantages of label-free detection, high sensitivity, small size, 
low cost and CMOS compatibility, this poly-Si NW biosensor is applicable for rapid point-of-care testing (POCT) 
and clinical applications. 
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